Werum is launching a new version of its PAS-X Manufacturing Execution System (MES): PAS-X 3.2, which will be globally available starting in January 2020. It covers biopharmaceutical and cell and gene therapy manufacturing, fast-growing industries that rely heavily on efficient digital processes.
 
“The main benefit for our customers is a reduced total cost of ownership thanks to, for instance, web start deployment, less administration effort as well as better update and upgrade capabilities,” says Olivier Néron, Senior Head of Product Management PAS-X 3.2, Werum IT Solutions. “We significantly enhance the user experience through integration of day-to-day technologies such as biometric authentication and the possibility to use PAS-X anywhere with any screen size. Our new PAS-X 3.2 is best suited to create the fully networked, automated and smart Pharma 4.0 biotech factory of the future.”
 
Werum has also added new functionality allowing the extension of master data information for material and equipment as well as master data elements that now all have a lifecycle and a version. New units of measure can be created within the system. Existing functionality like material flow has also been improved.
 
Legacy technologies have been decommissioned and substituted by up-to-date, light-weight HTML5 technologies. Deployment of PAS-X 3.2 will be facilitated using containers powered by Docker. For better maintenance, the application is now based on a micro-service architecture with binary delivery.